10-Q: VOXX International Reports Q3 Loss, Announces Merger Agreement with Gentex
Quarterly Report
VOXX International Corporation reports a net loss for Q3 2025 and announces a merger agreement with Gentex Corporation for $7.50 per share.
Summary
- VOXX International Corporation reported a net loss attributable to VOXX of $43.97 million, or $1.90 per share, for the three months ended November 30, 2024, compared to a net income of $1.91 million, or $0.08 per share, for the same period in 2023.
- Net sales decreased by 22.2% to $105.18 million from $135.26 million in the prior year.
- For the nine months ended November 30, 2024, the net loss attributable to VOXX was $50.82 million, or $2.20 per share, compared to a net loss of $19.89 million, or $0.85 per share, for the same period in 2023.
- Net sales for the nine-month period decreased by 19.8% to $289.32 million from $360.83 million in the prior year.
- The company recognized goodwill and intangible asset impairment charges totaling $44.26 million during the quarter.
- VOXX entered into a merger agreement with Gentex Corporation on December 17, 2024, where Gentex will acquire all outstanding shares of VOXX for $7.50 per share in cash.
- The transaction is expected to close in the first six months of calendar year 2025.
- The company received a Nasdaq delisting notification due to the delayed filing of the Form 10-Q but believes the filing will regain compliance.
Sentiment
Score: 3
Explanation: The document presents a negative financial performance for the quarter, including a significant net loss and declining sales. While a merger agreement offers a potential positive outcome for shareholders, the overall tone is pessimistic due to the poor financial results and Nasdaq delisting notification.
Positives
- VOXX entered into a merger agreement with Gentex Corporation, providing shareholders with $7.50 per share in cash.
- The company believes the filing of the Form 10-Q will allow them to regain compliance with Nasdaq listing rules.
- The company is implementing cost-cutting measures and headcount reductions to improve profitability.
- The company is relocating its OEM manufacturing operations to Mexico, which is expected to improve margins.
- The company completed the sale of its manufacturing facility in Lake Nona, Florida for $20 million.
Negatives
- VOXX reported a significant net loss of $43.97 million for Q3 2025, compared to a net income of $1.91 million in Q3 2024.
- Net sales declined 22.2% year-over-year to $105.18 million.
- The company recognized significant goodwill and intangible asset impairment charges of $44.26 million.
- The company received a Nasdaq delisting notification due to the delayed filing of the Form 10-Q.
- The company experienced a decline in sales of some of its high margin products, such as aftermarket security and aftermarket rear seat entertainment.
Risks
- The merger with Gentex is subject to customary closing conditions, and there is no guarantee that the transaction will be completed.
- Uncertainties related to the merger could negatively impact relationships with customers, employees, and other third parties.
- The company's ability to execute its business strategies and attain financial goals may be affected by restrictions imposed by the merger agreement.
- The company's financial performance is subject to macroeconomic factors, including recessions, interest rates, fuel prices, inflation, and foreign currency fluctuations.
- Continued negative trends in the business, as well as the narrow differences between fair value and carrying value of the Klipsch and DEI reporting units and Klipsch's indefinite-lived intangible asset, may result in an impairment charge related to the goodwill or indefinite-lived intangible asset in the future.
Future Outlook
The transaction with Gentex is expected to close during the first six months of calendar year 2025. The Company continues to focus on cash flow and anticipates having sufficient resources to operate for the coming twelve-month period.
Management Comments
- Management is taking actions to mitigate macroeconomic headwinds, including price increases and supply chain improvements.
- The Company continues to introduce new products across its segments and focus on driving operational improvements, discipline, and efficiencies through cost cutting measures and headcount reductions.
- The Company continues to focus on cash flow and anticipates having sufficient resources to operate for the coming twelve-month period.
Industry Context
The report acknowledges the impact of macroeconomic factors such as recessions, interest rates, fuel prices, inflation, and international tariffs on the company's performance. These factors are affecting customer purchases and supply chain constraints, leading to a decline in demand for many of VOXX's products.
Comparison to Industry Standards
- The document does not provide specific comparisons to industry standards or competitors.
- However, it mentions that the company operates in the Automotive Electronics, Consumer Electronics, and Biometrics industries, suggesting that its performance can be benchmarked against other companies in these sectors.
- The document notes that the company's objective is to continue to grow its business by acquiring new brands, embracing new technologies, expanding product development, and applying this to a continued stream of new products that should increase gross margins and improve operating income.
Related Party Transactions
- EyeLock LLC entered into a joint venture agreement with GalvanEyes Partners LLC to form BioCenturion LLC, with GalvanEyes controlling the day-to-day operations.
- Gentex Corporation, the largest shareholder of Voxx's Class A Common Stock, acquired GalvanEyes LLC.
- Steven Downing, CEO of Gentex Corporation, serves as a member of Voxx's Board of Directors.
Stakeholder Impact
- Shareholders will receive $7.50 per share in cash upon completion of the merger with Gentex.
- Employees may experience uncertainty about their future roles following the consummation of the merger.
- Customers and other third parties may seek to change existing business relationships with VOXX due to uncertainty about the pendency of the merger.
Next Steps
- The company needs to obtain stockholder approval for the merger agreement with Gentex.
- The company needs to satisfy customary closing conditions to complete the merger with Gentex.
- The company needs to regain compliance with Nasdaq listing rules.
Key Dates
| Date | Description |
|---|---|
| July 8, 2019 | Date of original employment agreements with Patrick M. Lavelle and Loriann Shelton. |
| September 8, 2021 | Onkyo Technology KK joint venture was created. |
| August 25, 2022 | Promissory note with EyeLock LLC was amended and restated. |
| February 6, 2023 | Beat Kahli appointed President of the Company. |
| February 29, 2024 | End of fiscal year 2024. |
| March 1, 2024 | Patrick Lavelle resumed role of President; EyeLock LLC entered into joint venture agreement with GalvanEyes Partners LLC to form BioCenturion LLC. |
| August 15, 2024 | Premium Audio Company, LLC completed the sale of certain trade names and related inventory to Jamo Holding Limited and Cinemaster Shanghai Ltd. |
| August 30, 2024 | VOXX Accessories Corp. completed the sale of certain assets of its domestic accessories business to Talisman Brands Inc. |
| September 24, 2024 | Company completed the sale of its manufacturing facility in Lake Nona, Florida. |
| November 1, 2024 | GalvanEyes LLC was acquired by Gentex Corporation. |
| November 11, 2024 | Employment agreements with Patrick M. Lavelle and Loriann Shelton were amended. |
| November 30, 2024 | End of the reporting period for this 10-Q filing. |
| December 17, 2024 | VOXX entered into a merger agreement with Gentex Corporation. |
| December 31, 2024 | Fifth amendment to the Employment Agreement with Patrick M. Lavelle and Sixth amendment to the Employment Agreement with Loriann Shelton. |
| January 28, 2025 | Company received a Nasdaq delisting notification. |
| February 7, 2025 | Date of this 10-Q filing. |
| First six months of 2025 | Expected closing of the merger with Gentex Corporation. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.